Proposed merger anticipated to close in 2025 As part of the proposed merger, Pulmatrix currently intends to divest its assets including its ...

According to Research by SNS Insider, global allergic conjunctivitis market growth is fueled by increasing allergy incidences, improved diagnosis, and novel treatment developments.Austin, Aug. 06, ...

India's Divi's Laboratories reported first-quarter profit below estimates on Wednesday, as manufacturers producing generic ...

Broad cap indices saw higher selling pressure. The Nifty midcap 100 index was down 0.54 per cent and Nifty smallcap 100 index ...

The US government has long sought to shift pharmaceutical manufacturing back to domestic soil, citing both economic and ...

In conclusion, several Nifty 50 stocks, including Cipla, Sun Pharma and Infosys, experienced declines in Wednesday's trading ...

LASCO Distributors reported a 15.3 per cent drop in net profit to $304 million for Q1 2025/26, with revenues dipping slightly ...

Indian pharmaceutical companies are preparing to launch generic versions of Novo Nordisk's weight-loss drug, semaglutide, potentially reducing its price by up to 80%.

Pharma stocks such as Sun Pharma, Cipla, Dr Reddy’s Laboratories, Lupin, and others will be in focus on Wednesday after US ...

Markets open flat ahead of RBI MPC decision; watch for updates on repo rate, inflation, and key stock movers today.

Sensex, Nifty, RBI MPC, market opening, Bharti Airtel, Shriram Finance, Asian Paints, Coal India, stock market today, August ...

Welcome to the Cipla Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most prominent ...